Muscular Dystrophy (DMD)
3 clinical trials · Condition
◉ Watch Muscular Dystrophy (DMD)
| Record | Firm | Date |
|---|---|---|
| Efficacy, Safety, and Tolerability of Zeleciment Rostudirsen (DYNE-251) Administered Intravenously Every 4 Weeks in Ambulatory Participants With Duchenne Muscular Dystrophy (FORZETTO) (NCT07608432) | Dyne Therapeutics | 2026-06-01 |
| A Multicenter Cohort Study of Duchenne and Becker Muscular Dystrophy in Western Chinese Children (NCT07511920) | West China Second University Hospital | 2026-04-20 |
| Study of an Investigational Drug, RO7239361 (BMS-986089), in Ambulatory Boys With DMD (NCT02515669) | Hoffmann-La Roche | 2015-12-02 |
Track Muscular Dystrophy (DMD) automatically
Every clearance here is in the API, with alerts when new ones post.